Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.
CurifyLabs is a healthtech company focused on the automated compounding of personalized medicines in pharmacies and hospitals.
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Oncorena treatment for renal cancer
Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.
Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners.
Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Leading provider of digital therapeutics for mental health: 10 DTx, 6 PDTx with universal reimbursement for 73m+ people, 33 clinical studies
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.
Elsa is a platform for patient-driven research for better drugs, health, and prevention.
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Providing RWA tokenization to traditional asset management
ReelFruit is a fruit agribusiness in Nigeria.
Doctrin provides decision support systems and communication tools to healthcare providers.
HealthCap has invested in 37 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
HealthCap's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 25 different industry categories.
Among tracked funding rounds, Ultragenyx Pharmaceutical received $400.0M in a Post-IPO Debt round. HealthCap's total known invested capital is $1.6B.
HealthCap's average investment size is $47.1M across its portfolio of 37 companies.
Recent HealthCap portfolio additions include Carisma Therapeutics, CurifyLabs, Pretzel Therapeutics, Oncorena, Modus Therapeutics. These companies were founded in 2020 or later.